Inhibition of human ADAMTS5 using 43-mer-VQTVTWPDMELPLPRNITEGEARGSVILTVKPIFEVSPSPLKG as substrate in presence of Lewis rat plasma measured after 3 hrs by AlphaScreen assay
Inhibition of human MMP1 using Mca-PQGL-(3-[2,4-dinitrophenyl]-L-2,3-diaminopropionyl)-AR-OH as substrate measured after 2 to 4 hrs by fluorescence analysis
Inhibition of human MMP2 using Mca-PQGL-(3-[2,4-dinitrophenyl]-L-2,3-diaminopropionyl)-AR-OH as substrate measured after 2 to 4 hrs by fluorescence analysis
Inhibition of human MMP3 using Mca-PQGL-(3-[2,4-dinitrophenyl]-L-2,3-diaminopropionyl)-AR-OH as substrate measured after 2 to 4 hrs by fluorescence analysis
Inhibition of human MMP7 using Mca-PQGL-(3-[2,4-dinitrophenyl]-L-2,3-diaminopropionyl)-AR-OH as substrate measured after 2 to 4 hrs by fluorescence analysis
Inhibition of human MMP9 using Mca-PQGL-(3-[2,4-dinitrophenyl]-L-2,3-diaminopropionyl)-AR-OH as substrate measured after 2 to 4 hrs by fluorescence analysis
Inhibition of human MMP13 using Mca-PQGL-(3-[2,4-dinitrophenyl]-L-2,3-diaminopropionyl)-AR-OH as substrate measured after 2 to 4 hrs by fluorescence analysis
Inhibition of human MMP14 using Mca-PQGL-(3-[2,4-dinitrophenyl]-L-2,3-diaminopropionyl)-AR-OH as substrate measured after 2 to 4 hrs by fluorescence analysis
Inhibition of human TACE using Mca-PQGL-(3-[2,4-dinitrophenyl]-L-2,3-diaminopropionyl)-AR-OH as substrate measured after 2 to 4 hrs by fluorescence analysis
Reduction in ADAMTS-4/ADAMTS-5 mediated aggrecan cleavage products in Lewis rat model of MIA assessed as aggrecanase-cleaved fragments at 10 mg/kg, po bid administered post 3 days MIA induction measured after 4 hrs of last dosage on day 7 by NITEGE sandwich ELISA
Reduction in ADAMTS-4/ADAMTS-5 mediated aggrecan cleavage products in Lewis rat model of MIA assessed as aggrecanase-cleaved fragments at 30 mg/kg, po bid administered post 3 days MIA induction measured after 4 hrs of last dosage on day 7 by NITEGE sandwich ELISA
Reduction in ADAMTS-4/ADAMTS-5 mediated aggrecan cleavage products in Lewis rat model of MIA assessed as aggrecanase-cleaved fragments at 100 mg/kg, po bid administered post 3 days MIA induction measured after 4 hrs of last dosage on day 7 by NITEGE sandwich ELISA